Higher levels of cancer-specific anxiety were associated with poor sexual function and indicators of depression among men who underwent surgery to treat prostate cancer. The researchers hypothesized that cancer-specific anxiety would affect quality of life in men who had prostatectomy. “The 10-year survival for a man undergoing surgery to remove localized prostate cancer is greater than 95%,” Alexander Parker, PhD, an associate professor of epidemiology and urology at Mayo Clinic in Jacksonville, Fla., said in a press release. “Given that the majority of men who undergo prostatectomy for prostate cancer will not die from their disease, we are concerned about what life will be like for these patients decades after diagnosis and treatment.”
Tags: anxiety, Cancer, cancer-specific anxiety, Dr. Alexander Parker, Helio, Mayo Clinic Jacksonville, prostate cancer, prostatectomy, Research, Urology